Drug Type Small molecule drug |
Synonyms HY 078020, HY-078020, HY078020 |
Target |
Action antagonists |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Urticaria | Phase 1 | China | 13 Nov 2024 | |
Anaphylaxis | Preclinical | China | 03 Feb 2024 |